Organometallic Anticancer Compounds
Open Access
- 15 November 2010
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (1), 3-25
- https://doi.org/10.1021/jm100020w
Abstract
No abstract availableThis publication has 173 references indexed in Scilit:
- Exploring metallodrug–protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compoundJBIC Journal of Biological Inorganic Chemistry, 2009
- Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivoBritish Journal of Cancer, 2007
- Identification of (η6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(η6-p-cymene)RuCl2(DMSO)] to stress-regulated proteins and to helicasesJBIC Journal of Biological Inorganic Chemistry, 2007
- Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in miceAnti-Cancer Drugs, 2007
- Intracellular mapping of the distribution of metals derived from the antitumor metallocenesJBIC Journal of Biological Inorganic Chemistry, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Transition-Metal-Mediated Synthesis of Novel Carbocyclic Nucleoside Analogues with Antitumoral ActivityChemistry – A European Journal, 2004
- Inflammation and cancerNature, 2002
- Polymeric organoiron compounds as prodrugs in cancer research*Macromolecular Symposia, 2001
- Bioorganometallic Chemistry – Synthesis and Antitumor Activity of Cobalt Carbonyl ComplexesArchiv der Pharmazie, 1997